US advances first federally funded ibogaine trials
Regulators are seeking public input on trial design and safety standards as federally funded studies explore ibogaine for opioid addiction and PTSD.
Read at Reuters →Daily healthcare briefing
5 October 2026
Ibogaine research, radiopharma investment and multi-cancer detection.
GE HealthCare expands its radiopharma footprint
GE HealthCare agreed to acquire Sofie Biosciences for $945 million, adding PET-imaging capacity and US rights to the experimental cancer-imaging agent FAPI-74.
Read at Reuters →Multi-cancer blood testing moves closer to FDA decision
An FDA advisory panel’s preliminary support has moved Grail’s Galleri test closer to a landmark decision, while evidence and insurance coverage remain central questions.
Read at Reuters →Editorial summaries for general information only; not medical advice. Research findings and company announcements should be read in their original context.